Table 1: Characteristics and demographics of the study populations.
Jewish | Arabs | p | |
Total population | 431,828 (70.1%) | 184,510 (29.9%) | |
IBD patients | 2,050 | 263 | |
Prevalence | 480/100.000 | 140/100.000 | < 0.001 |
Age at diagnosis (y) | 41.1 ± 18.8 | 35.6 ± 16.2 | < 0.001 |
BMI | 25.3 ± 6 | 25 ± 5.1 | 0.64 |
Male/Female | 994 (48.5%)/1056 (51.5%) | 131 (49.8%)/132 (50.2%) | 0.68 |
CD/UC | 1,070 (52%)/980 (48%) | 134 (51%)/129 (49%) | 0.7 |
Diabetes | 224 (10.9%) | 47 (17.9%) | < 0.001 |
Dyslipidemia | 789 (38.5%) | 73 (27.8%) | < 0.001 |
Lipid lowering drugs | 338 (16.5%) | 23 (8.7%) | < 0.001 |
NSAID's use | 591 (25.1%) | 81 (30.8%) | 0.5 |
Aspirin use | 550 (26.8%) | 66 (25.1%) | 0.54 |
CD: Crohn's Disease, UC: Ulcerative Colitis, NSAIDS: Non-Steroidal Anti-Inflammatory Drugs.